China Meheco Group announced that the company received a letter regarding the proposal by Chongqing Huayi Holdings (Group) Co., Ltd. to hold an interim meeting of the shareholders of Chongqing Medical Health Industry Co., Ltd. The shareholders of the associated company Chongqing Yijian, Chongqing Huayi Group, plan to transfer their 49% equity in Chongqing Yijian to Chongqing Yufu through a private agreement, with the transfer price set at 4.507 billion yuan. The company intends to waive its preemptive right for the 49% equity. This waiver of preemptive rights does not constitute a related-party transaction and does not involve any major asset restructuring. The waiver of preemptive rights was approved at the 22nd meeting of the 9th Board of Directors and still requires submission for shareholder approval. This waiver of preemptive rights does not lead to any change in the scope of the company's consolidated financial statements, nor will it cause a decrease in the company's shareholding ratio in Chongqing Yijian. There are no situations that would harm the interests of the company and its shareholders, and it will not have a significant impact on the company's financial and operational status.